Literature DB >> 8264509

Abnormal renal magnesium handling.

R A Sutton1, S Domrongkitchaiporn.   

Abstract

The normal fractional urinary excretion of filtered magnesium is about 5%. In magnesium deficiency in man, the kidneys can normally reduce the 24-hour urinary magnesium excretion to less than 1 mmol (24 mg) via unknown mechanisms, and initially without a fall in plasma magnesium concentration. Renal magnesium wasting may be defined as a urinary excretion greater than 1 mmol/day in the presence of hypomagnesemia (plasma magnesium < 0.7 mmol/l). Congenital renal magnesium wasting occurs in several syndromes including Bartter's syndrome in which it is associated with hypercalciuria, and the defect may be in the thick ascending limb of Henle's loop, and Gitelman's syndrome in which there is hypocalciuria, and the defect may be in the distal convoluted tubule. Other causes of renal magnesium wasting include diabetes mellitus, hypercalcemia and diuretics. Magnesium wasting may also result from various toxicities including those of cis-platinum, in which the biochemical features resemble Gitelman's syndrome, and those of aminoglycosides, pentamidine and cyclosporin. Calcitriol deficiency may also contribute to renal magnesium wasting in some circumstances. Mild hypermagnesemia may occur in familial hypocalciuric hypercalcemia and may reflect abnormal sensitivity of the loop of Henle to calcium and magnesium ions. By contrast, the hypermagnesemia that occurs in chronic renal failure results from the reduced glomerular filtration of magnesium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264509

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  11 in total

Review 1.  Hypomagnesemia and hypermagnesemia.

Authors:  Joel Michels Topf; Patrick T Murray
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.

Authors:  Wouter M Tiel Groenestege; Stéphanie Thébault; Jenny van der Wijst; Dennis van den Berg; Rob Janssen; Sabine Tejpar; Lambertus P van den Heuvel; Eric van Cutsem; Joost G Hoenderop; Nine V Knoers; René J Bindels
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Clinical presentation and outcome in primary familial hypomagnesaemia.

Authors:  H Shalev; M Phillip; A Galil; R Carmi; D Landau
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

4.  Hormonal disturbances in visceral leishmaniasis (kala-azar).

Authors:  Frederico Araujo Lima Verde; Francisco Agenor Araujo Lima Verde; Augusto Saboia Neto; Paulo César Almeida; Emir Mendonça Lima Verde
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

Review 5.  Molecular determinants of magnesium homeostasis: insights from human disease.

Authors:  R Todd Alexander; Joost G Hoenderop; René J Bindels
Journal:  J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 10.121

6.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Jameela A Kari; Mohammed Farouq; Hammad O Alshaya
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

Review 7.  Genetics of hereditary disorders of magnesium homeostasis.

Authors:  Karl P Schlingmann; Martin Konrad; Hannsjörg W Seyberth
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

Review 8.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

Review 9.  Hypomagnesemia in critically ill patients.

Authors:  Bent-Are Hansen; Øyvind Bruserud
Journal:  J Intensive Care       Date:  2018-03-27

Review 10.  An overview of diagnosis and management of drug-induced hypomagnesemia.

Authors:  George Liamis; Ewout J Hoorn; Matilda Florentin; Haralampos Milionis
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.